Table of Contents
ISRN Cardiology
Volume 2012 (2012), Article ID 326809, 9 pages
http://dx.doi.org/10.5402/2012/326809
Research Article

Comparison of the Effects of Adenosine, Inosine, and Their Combination as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction

1Laboratory of Biosurgical Research, Alain Carpentier Foundation, University Paris Descartes, 75015 Paris, France
2Department of Pathology, Saint Joseph Hospital, 75014 Paris, France

Received 22 November 2011; Accepted 22 December 2011

Academic Editors: A. Bobik and A. V. Bruschke

Copyright © 2012 Abdel Shafy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. T. Sommerschild and K. A. Kirkeboen, “Adenosine and cardioprotection during ischemia and reperfusion—overview,” Acta Anaesthesiologica Scandinavica, vol. 44, no. 1-2, pp. 1038–1055, 2000. View at Google Scholar
  2. J. P. Headrick, B. Hack, and K. J. Ashton, “Acute adenosinergic cardioprotection in ischemic-reperfused hearts,” The American Journal of Physiology, vol. 285, no. 5, pp. H1797–H1818, 2003. View at Google Scholar · View at Scopus
  3. E. Teusher and V. Weidlich, “Adenosine nucleotides, adenosine and adenine as angiogenesis factors,” Biomedica Biochimica Acta, vol. 44, no. 3, pp. 493–495, 1985. View at Google Scholar
  4. T. H. Adair, “Growth regulation of the vascular system: an emerging role for adenosine,” The American Journal of Physiology, vol. 289, no. 2, pp. R283–R296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. H. Adair, R. Cotten, J. W. Gu et al., “Adenosine infusion increases plasma levels of VEGF in humans,” BMC Physiology, vol. 5, article 10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. N. M. Buckley, K. K. Tsuboi, and N. J. Zeig, “Inotropic effects of purines and pyrimidines on the isolated heart,” Circulation Research, vol. 9, pp. 242–249, 1961. View at Publisher · View at Google Scholar
  7. C. E. Jones, J. X. Thomas, M. D. Devous, C. P. Norris, and E. E. Smith, “Positive inotropic response to inosine in the in situ canine heart,” The American Journal of Physiology, vol. 233, no. 4, pp. H438–H443, 1977. View at Google Scholar · View at Scopus
  8. O. A. Smiseth, P. Gunnes, T. Sand, and O. D. Mjos, “Inosine causing insulin release and increased myocardial uptake of carbohydrates relative to free fatty acids in dogs,” Clinical Physiology, vol. 9, no. 1, pp. 27–38, 1989. View at Google Scholar · View at Scopus
  9. C. E. Jones and L. R. Mayer, “Nonmetabolically coupled coronary vasodilatation during inosine infusion in dogs,” The American Journal of Physiology, vol. 7, no. 4, pp. H569–H574, 1980. View at Google Scholar · View at Scopus
  10. M. W. Connolly, E. A. Grossi, J. Slater, and K. H. Krieger, “Inosine enhances salvage of reperfused myocardium,” Current Surgery, vol. 42, no. 6, pp. 469–471, 1985. View at Google Scholar · View at Scopus
  11. M. Giannecchini, M. Matteucci, R. Pesi, F. Sgarrella, M. G. Tozzi, and M. Camici, “Uptake and utilization of nucleosides for energy repletion,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 4, pp. 797–808, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Birk, K. A. Petersen, C. Kruuse et al., “The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects,” Cephalalgia, vol. 25, no. 5, pp. 369–377, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Soricelli, A. Postiglione, A. Cuocolo et al., “Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease,” Stroke, vol. 26, no. 9, pp. 1572–1576, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Mahaffey, J. A. Puma, N. A. Barbagelata et al., “Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial,” Journal of the American College of Cardiology, vol. 34, no. 6, pp. 1711–1720, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Quintana, P. Hjemdahl, A. Sollevi et al., “Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study,” European Journal of Clinical Pharmacology, vol. 59, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar
  16. A. M. Ross, R. J. Gibbons, G. W. Stone, R. A. Kloner, and R. W. Alexander, “A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II),” Journal of the American College of Cardiology, vol. 45, no. 11, pp. 1775–1780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ohnishi, I. Biaggioni, G. Deray, R. A. Branch, and E. K. Jackson, “Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats,” Hypertension, vol. 8, no. 5, pp. 391–398, 1986. View at Google Scholar · View at Scopus
  18. D. L. Johnston, J. R. Daley, D. O. Hodge, M. R. Hopfenspirger, and R. J. Gibbons, “Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients,” Mayo Clinic Proceedings, vol. 70, no. 4, pp. 331–336, 1995. View at Google Scholar · View at Scopus
  19. S. Bokhari, E. P. Ficaro, and B. D. McCallister, “Adenosine stress protocols for myocardial perfusion imaging,” Journal of Nuclear Cardiology, vol. 14, no. 3, pp. 415–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. DiMarco, T. D. Sellers, and R. M. Berne, “Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia,” Circulation, vol. 68, no. 6, pp. 1254–1263, 1983. View at Google Scholar · View at Scopus
  21. Y. Yabe and S. Yoshimura, “Effect of inosine on left ventricular performance and its clinical significance,” Japanese Heart Journal, vol. 22, no. 6, pp. 915–928, 1981. View at Google Scholar · View at Scopus
  22. D. M. Aviado, “Inosine: a naturally occurring cardiotonic agent,” Journal de Pharmacologie, vol. 14, pp. 47–71, 1983. View at Google Scholar · View at Scopus
  23. N. I. Lanovaia and E. M. Neiko, “Use of riboxin in treating patients with chronic ischemic disease,” Vrachbnoe Delo, no. 8, pp. 17–19, 1986. View at Google Scholar
  24. I. Azancot, A. Piekarski, A. Nguyen et al., “Dose related effects of inosine on left ventricular pump function in man. A computerized hemodynamic and echocardiographic study,” Acta Therapeutica, vol. 8, pp. 283–299, 1982. View at Google Scholar
  25. G. Haskó, D. G. Kuhel, Z. H. Németh et al., “Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock,” Journal of Immunology, vol. 164, no. 2, pp. 1013–1019, 2000. View at Google Scholar
  26. L. I. Benowitz, D. E. Goldberg, J. R. Madsen, D. Soni, and N. Irwin, “Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury,” Proceedings of the National Academy of Sciences of the United States, vol. 96, no. 23, pp. 13486–13490, 1999. View at Google Scholar
  27. L. I. Benowitz, D. E. Goldberg, J. R. Madsen, D. Soni, and N. Irwin, “Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13486–13490, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Chen, D. E. Goldberg, B. Kolb, M. Lanser, and L. I. Benowitz, “Inosine induces axonal rewiring and improves behavioral outcome after stroke,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 9031–9036, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Ward, A. Sherali, Z. P. Mo, and C. M. Tse, “Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine,” Journal of Biological Chemistry, vol. 275, no. 12, pp. 8375–8381, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Miura, Y. Liu, H. Kita, T. Ogawa, and K. Shimamoto, “Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation,” Journal of the American College of Cardiology, vol. 35, no. 1, pp. 238–245, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Sato, N. Sasaki, B. O'Rourke, and E. Marban, “Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?” Circulation, vol. 102, no. 7, pp. 800–805, 2000. View at Google Scholar · View at Scopus
  32. D. M. Yellon and D. J. Hausenloy, “Myocardial perfusion injury,” The New England Journal of Medicine, vol. 357, pp. 1121–1135, 2007. View at Google Scholar
  33. S. Javadov and M. Karmazyn, “Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection,” Cellular Physiology and Biochemistry, vol. 20, no. 1–4, pp. 1–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ohta and M. Sitkovsky, “Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage,” Nature, vol. 414, no. 6866, pp. 916–920, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. B. N. Cronstein, “Adenosine, an endogenous anti-inflammatory agent,” Journal of Applied Physiology, vol. 76, no. 1, pp. 5–13, 1994. View at Google Scholar · View at Scopus
  36. R. A. G. Patel, D. K. Glover, A. Broisat et al., “Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist,” The American Journal of Physiology, vol. 297, no. 2, pp. H637–H642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Q. Zhao, M. W. Williams, H. Sato et al., “Acadesine reduces myocardial infarct size by an adenosine mediated mechanism,” Cardiovascular Research, vol. 29, no. 4, pp. 495–505, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. C. G. da Silva, R. Jarzyna, A. Specht, and E. Kaczmarek, “Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells,” Circulation Research, vol. 98, no. 5, pp. e39–e47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Claeys, J. Bosmans, M. de Ceuninck et al., “Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 9–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. L. Fokkema, P. J. Vlaar, M. Vogelzang et al., “Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction a randomized controlled trial,” Circulation, vol. 2, no. 4, pp. 323–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. R. A. Kloner, M. B. Forman, R. J. Gibbons, A. M. Ross, R. W. Alexander, and G. W. Stone, “Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial,” European Heart Journal, vol. 27, no. 20, pp. 2400–2405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Kitakaze and M. Hori, “Adenosine therapy: a new approach to chronic heart failure,” Expert Opinion on Investigational Drugs, vol. 9, no. 11, pp. 2519–2535, 2000. View at Google Scholar · View at Scopus
  43. H. Hayashi, S. Hirai, H. Harayama, T. Saito, and A. Ichikawa, “Identification of hypoxantine and inosine in brain dialyzable fraction as stimulators of growth of porcine aortic endothelial cells in response to fibroblast growth factor in either dialyzed serum media or low serum media,” The Japanese Journal of Pharmacology, vol. 53, no. 1, pp. 1–9, 1990. View at Google Scholar
  44. P. Parsons-Wingerter, K. E. Elliott, J. I. Clark, and A. G. Farr, “Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 5, pp. 1250–1256, 2000. View at Google Scholar · View at Scopus